PHR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Phreesia Inc (PHR) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock faces significant challenges, including insider selling, legal investigations, and declining financial performance. While analysts maintain positive ratings, the stock's technical indicators and lack of strong proprietary trading signals suggest a cautious approach. Holding off on buying until clearer positive catalysts emerge would be prudent.
The MACD is positive and expanding, suggesting mild bullish momentum. However, the RSI is neutral at 52.023, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels indicate limited upside potential in the short term, with resistance at 12.825 and support at 11.721.
Analysts maintain positive ratings, with most firms assigning Buy or Outperform ratings. The company has shown revenue growth of 12.67% YoY in the latest quarter.
Insider selling has increased significantly (495.07% over the last month). Legal investigations into potential securities law violations are ongoing. The stock has underperformed following a disappointing earnings call and faces skepticism around sustainable top-line growth. Net income and EPS have declined sharply YoY (-129.65% and -128.00%, respectively).
In Q3 2026, revenue increased by 12.67% YoY to $120.33M, but net income dropped by 129.65% YoY to $4.27M. EPS also declined by 128.00% YoY to $0.07. Gross margin improved slightly to 62.18%, up 1.88% YoY.
Analysts generally maintain a positive outlook, with price targets ranging from $22 to $30 and Buy/Outperform ratings. However, price targets have been lowered recently due to competitive risks and skepticism about growth sustainability.
